BECOME A MEMBER - Get Unlimited CE

  • SIGN IN
  • GET HELP
    •  

    Webinar Details

    Event Type

    Live Online

    Date

    Tuesday, November 12, 2024

    Time

    10:30 AM - 11:30 AM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1 Contact Hour(s)

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $30.00

    • Overview

      Is naloxone everywhere and nowhere at the same time? Recent FDA approvals have enabled the distribution of naloxone products via the over-the-counter (OTC) supply chain, while still being available in multiple formulations via prescription. Is enabling OTC sales of naloxone the panacea of “ending the opioid crisis” as we know it? Let’s slow down a bit and mitigate the hysteria and confusion beyond the relatively straight-forward administration of naloxone products. This program will review the signs and symptoms of opioid overdose, the FDA-approved OTC and prescription opioid overdose respiratory depression reversal products, the opioid overdose respiratory depression reversal medication administration guidelines, and general important pharmacological characteristics of the mu-opioid antagonist naloxone. Naloxone saves lives by reversing opioid overdose respiratory depression, let’s respect its pharmacology, address its realities, and go save some lives!


      Financial Support By

      PharmCon

    • Pharmacist

      Recognize opioid overdose symptoms
      Identify clinically important pharmacological characteristics of naloxone
      Recall FDA-approved over-the-counter (OTC) and prescription (Rx) opioid overdose respiratory depression reversal naloxone products and administration guidelines

      Pharmacy Technician

      Recognize opioid overdose symptoms
      Identify clinically important pharmacological characteristics of naloxone
      Recall FDA-approved over-the-counter (OTC) and prescription (Rx) opioid overdose respiratory depression reversal naloxone products and administration guidelines

      Nurse

      Recognize opioid overdose symptoms
      Identify clinically important pharmacological characteristics of naloxone
      Recall FDA-approved over-the-counter (OTC) and prescription (Rx) opioid overdose respiratory depression reversal naloxone products and administration guidelines

    • Repeat Presentation

      This presentation was last given on 4/12/2024 10:30 AM

      Future Airings

      There are no future airings of this activity scheduled at this time.

    • Activity Type

      Knowledge

      CE Broker

      20-1096406

      Universal Activity Number

      Pharmacist 0798-0000-23-238-L08-P

      Pharmacy Technician 0798-0000-23-238-L08-T

      Nurse 0798-0000-23-238-L08-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must respond to all randomly-generated participation checks and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


    HARDWARE REQUIREMENTS
    Windows 8.1
    Windows 10
    Apple Mac OS X 10.13 or higher
    iOS 10+
    Android 4.3+


    SOFTWARE REQUIREMENTS
    Google Chrome
    Mozilla Firefox

    Log in locally; do not log in using a VPN, cloud server, remote desktop, etc.


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon. Through this notice, PharmCon. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.

     

    LEARN

    LIVE CE

    HOME STUDY CE

    NEWS

    SPECIALTY CERTIFICATES

    SUPPORT

    ABOUT

    RESOURCES

    CE REPORTING

    CAREER ASSISTANCE

    PATIENT CARE INFO

     

    CE ACTIVITY

    ACCOUNT

    (843) 488 5550 Office

    (843) 488 5554 Fax

    info@freeCE.com Email

    www.freeCE.com Web

    201 N. King of Prussia Rd, Suite 370
    Radnor, PA 19087     Address


     

    ©  PharmCon All Rights Reserved.

    Terms & Conditions

    Privacy Policy

    freeCE is a division of PharmCon